Skip to search.
 All Ordinaries Up0.78%

More On NRT.AX



News & Info


Analyst Coverage



Novogen Ltd (NRT.AX)

0.20 0.00(0.00%) 30 Jul 16:11
Add to Portfolio
ProfileGet Profile for:
Novogen Ltd
16 - 20 Edgeworth David Avenue
Suite 1
Hornsby, NSW 2077
Australia - Map
Phone: 61 2 9472 4100
Fax: 61 2 9476 0388

Index Membership:N/A
Industry:Drug Manufacturers - Major
Full Time Employees:N/A

Business Summary 

Novogen Limited is engaged in the pharmaceutical research and development business in Australia. The company has primarily two drug technology platforms, which include super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). Its SBPs technology platform offers drug candidates, which include Cantrixil, an intra-peritoneal product intended for the treatment of abdominal cancers, such as ovarian and pancreatic cancer; Trilexium that is intended for the treatment of neural cancers, including glioblastoma and neuroblastoma; and Trx-7 for the treatment of prostate cancer. The company’s ATMs technology platform targets the cytoskeleton of the cancer cell. Novogen Limited was founded in 1994 and is based in Hornsby, Australia.

Key Statistics

Company Websites 
Home Page
Search Yahoo!7 for:
More on Novogen Ltd

Key Executives 
Mr. Iain Gladstone Ross B.SC (HONS), C.DIR , 61
Acting Chief Exec. Officer and Director
Christine Bruce ,
Acting Chief Financial Officer and Financial Controller
Dr. David Brown B.App. Sc. (Hons), Ph.D., GradDip,
Chief Scientific Officer
Mr. Lionel Mateo BCL MCL,
Company Sec.
Dr. Andrew Heaton B.Sc (Hons) Ph.D.,
Vice-Pres of Drug Discovery, Manufacture & Patents
Amounts are as of 31/12/2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.
View Insiders